1. Home
  2. VRDN vs ARCO Comparison

VRDN vs ARCO Comparison

Compare VRDN & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • ARCO
  • Stock Information
  • Founded
  • VRDN 2006
  • ARCO 2007
  • Country
  • VRDN United States
  • ARCO Uruguay
  • Employees
  • VRDN N/A
  • ARCO N/A
  • Industry
  • VRDN Medical Specialities
  • ARCO Restaurants
  • Sector
  • VRDN Health Care
  • ARCO Consumer Discretionary
  • Exchange
  • VRDN Nasdaq
  • ARCO Nasdaq
  • Market Cap
  • VRDN 1.6B
  • ARCO 1.4B
  • IPO Year
  • VRDN N/A
  • ARCO 2011
  • Fundamental
  • Price
  • VRDN $21.65
  • ARCO $6.65
  • Analyst Decision
  • VRDN Strong Buy
  • ARCO Hold
  • Analyst Count
  • VRDN 11
  • ARCO 1
  • Target Price
  • VRDN $38.80
  • ARCO $8.80
  • AVG Volume (30 Days)
  • VRDN 658.9K
  • ARCO 1.3M
  • Earning Date
  • VRDN 11-11-2025
  • ARCO 11-12-2025
  • Dividend Yield
  • VRDN N/A
  • ARCO 3.61%
  • EPS Growth
  • VRDN N/A
  • ARCO N/A
  • EPS
  • VRDN N/A
  • ARCO 0.62
  • Revenue
  • VRDN $305,000.00
  • ARCO $4,496,793,000.00
  • Revenue This Year
  • VRDN N/A
  • ARCO $6.73
  • Revenue Next Year
  • VRDN $34,076.08
  • ARCO $7.76
  • P/E Ratio
  • VRDN N/A
  • ARCO $10.78
  • Revenue Growth
  • VRDN 5.90
  • ARCO 0.09
  • 52 Week Low
  • VRDN $9.90
  • ARCO $6.51
  • 52 Week High
  • VRDN $27.20
  • ARCO $10.03
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 66.74
  • ARCO 39.84
  • Support Level
  • VRDN $20.83
  • ARCO $6.54
  • Resistance Level
  • VRDN $19.97
  • ARCO $7.30
  • Average True Range (ATR)
  • VRDN 0.92
  • ARCO 0.17
  • MACD
  • VRDN 0.18
  • ARCO -0.02
  • Stochastic Oscillator
  • VRDN 91.56
  • ARCO 14.47

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About ARCO Arcos Dorados Holdings Inc. Shares

Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.

Share on Social Networks: